Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1135267.RAEp1wx9TBVhKAYpAX3aTWvX5C3JN2182WDlUuzQE6FEs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1135267.RAEp1wx9TBVhKAYpAX3aTWvX5C3JN2182WDlUuzQE6FEs130_assertion type Assertion NP1135267.RAEp1wx9TBVhKAYpAX3aTWvX5C3JN2182WDlUuzQE6FEs130_head.
- NP1135267.RAEp1wx9TBVhKAYpAX3aTWvX5C3JN2182WDlUuzQE6FEs130_assertion description "[We believe that RIP3 and MLKL could represent attractive targets for the management of human IBD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1135267.RAEp1wx9TBVhKAYpAX3aTWvX5C3JN2182WDlUuzQE6FEs130_provenance.
- NP1135267.RAEp1wx9TBVhKAYpAX3aTWvX5C3JN2182WDlUuzQE6FEs130_assertion evidence source_evidence_literature NP1135267.RAEp1wx9TBVhKAYpAX3aTWvX5C3JN2182WDlUuzQE6FEs130_provenance.
- NP1135267.RAEp1wx9TBVhKAYpAX3aTWvX5C3JN2182WDlUuzQE6FEs130_assertion SIO_000772 24322838 NP1135267.RAEp1wx9TBVhKAYpAX3aTWvX5C3JN2182WDlUuzQE6FEs130_provenance.
- NP1135267.RAEp1wx9TBVhKAYpAX3aTWvX5C3JN2182WDlUuzQE6FEs130_assertion wasDerivedFrom befree-2016 NP1135267.RAEp1wx9TBVhKAYpAX3aTWvX5C3JN2182WDlUuzQE6FEs130_provenance.
- NP1135267.RAEp1wx9TBVhKAYpAX3aTWvX5C3JN2182WDlUuzQE6FEs130_assertion wasGeneratedBy ECO_0000203 NP1135267.RAEp1wx9TBVhKAYpAX3aTWvX5C3JN2182WDlUuzQE6FEs130_provenance.